On September 20th, 2022, MSQ Ventures successfully co-hosted BioAroundWorld Global Cross-Border BioPharma together with BioAroundWorld. This event focuses on cross-border transactions in the healthcare sector between China and the US and biopharma industry technology and knowledge sharing. This time we brought a panel discussion and 5 knowledge-sharing presentations on this event. It attracted many corporate executives, R&D leaders, and investors from outstanding healthcare companies and top venture capital institutions in China and the US.

CASE STUDY: ImaginAB & DC Pharma Successful Case Study

MODERATOR: Echo Hindle-Yang, Founder & CEO, MSQ Ventures

PANELIST:
• Ian Wilson, Chief Executive Officer, ImaginAb
• Doug Chong, Head of BD Division, DC Pharm

KNOWLEDGE SHARING

Overall CGT Market Trend And Challenge In CMC
• Speaker: Jack Zhang, Senior Strategy Manager, CGT, Lonza

Insights For A New Solution For Neurodegenerative Diseases And What Is More
• Speaker: Christopher U Missling, PhD, President & CEO, Anavex Life Sciences

PEDF-derived Short Peptide Technology Platform Boosted Drug Development
• Speaker: Yi-Chun Maria Chen, VP of Business Development, BRIM Biotechnology

Zhiyi Biotech Novel LBPs Development
• Speaker: Avery Wen, BD Associate Director, Zhiyi Biotech

Senlang Biotech-An All-in-One CAR-T Therapy Platform
• Speaker: Jianqiang Li , PhD, Founder and CSO, Senlang Biotech